2020年版中成药治疗慢性肾脏病3-5期(非透析)临床应用指南解读

Interpretation of 2020 Version of The Clinical Application Guide of Chinese Patent Medicine in The Treatment of Chronic Kidney Disease Stage 3-5(Non Dialysis)

2020年《中成药治疗优势病种临床应用指南》标准化项目组正式发布了《中成药治疗慢性肾脏病3-5期(非透析)临床应用指南》。该指南基于解决临床关键问题,涵盖了临床常用的治疗慢性肾脏病的中成药的临床指标改善情况、使用条件、安全性及证据描述,共计8条推荐意见。结合指南,主要介绍该指南的制订背景和方法学,并对临床常用的治疗慢性肾脏病3-5期(非透析)的主要中成药的相关内容进行解读。

In 2020,the standardization project team of the Clinical Application Guide of Chinese Patent Medicine in The Treatment of Dominant Diseases officially released the Clinical Application Guide of Chinese Patent Medicine in The Treatment of Chronic Kidney Disease Phase 3-5(Non Dialysis).Based on solving key clinical problems,the guide covers the improvement of clinical indicators,use conditions,safety and evidence description of Chinese patent medicines commonly used in clinical treatment of chronic kidney disease,with a total of 8 recommendations.This paper introduces the background and methodology of the guideline,and interprets the relevant contents of the main Chinese patent medicines commonly used in the clinical treatment of stage 3-5(non dialysis)of chronic kidney disease.